Can hyperbaric oxygen be used to cure for Long COVID? A clinical trial.
- Conditions
- ong COVID, post-acute COVID-19 Syndrome, post COVID-19 Syndrome (ICD-10 U09.0)MedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1Level: PTClassification code 10057244Term: Post viral fatigue syndromeSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10063080Term: Postural orthostatic tachycardia syndromeSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]
- Registration Number
- EUCTR2021-000764-30-SE
- Lead Sponsor
- Karolinska University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 80
1)Aged 18–60 years
2)Healthy or mild systemic disease prior to COVID-19
3)Symptoms consistent with Long COVID for at least 12 weeks
4)Diagnosed with Long COVID, PACS, PCS (ICD-10 U09.9)
5)Working or studying prior to COVID-19
6)Documented informed consent according to ICH-GCP and national regulations
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 80
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
1)Known pregnancy or positive pregnancy test in women of childbearing age
2)ASA 3 or more from other cause than Long COVID
3)Score above 70 in RAND-36 domain Role Limitation Physical Health (RP) or Physical Functioning (PF)
4)Diabetes
5)Diagnosed with Hypertension prior to COVID-19
6)Contraindication for HBO2 treatment according to local guidelines
7)Participation or recent participation in a clinical trial with an investigational product
8)Mental inability, reluctance or language difficulties that result in difficulty understanding the meaning of trialstudy participation
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method